SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BJCT-BIOJECT-needle less injection product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GREG FINLEY who wrote (345)12/21/1998 9:46:00 AM
From: geewiz   of 534
 
Greg and BJCT Gang,

Thanks for the holiday cheer, and here's wishing you similar good tidings.

Remember the NBC news on Powderject several weeks ago? As a follow up I found this interesting short piece in the London Financial Times on December 8,1998;

For private use;

POWDERJECT IN VACCINE ADVANCE

In a trial by Powderject Pharmaceuticals, a UK biotechnology company, has become the first in the world to elicit a protective immune response in humans using a DNA vaccine.

The company, which is developing DNA vaccines with Glaxo Welcome, yesterday said all 11 patients that had completed a Phase I study for a DNA vaccine against Hepatitis B,, a potentially fatal liver condition had developed sufficient antibodies to protect them against the disease. ...........

Other companies are developing DNA vaccines but Powderject last week won a European patent for its delivery technology. This enables DNA to be administered into the body by attaching it to microscopic gold particles propelled into the skin at supersonic speed using a helium jet. The method is up to 1,000 times more efficient than conventional injection.
...............

I remember we were delivering Hepatitis vaccines, but I certain they were not based on a DNA platform. Regardless, the efficiency claimed is noteworthy.

holiday best to all, art
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News